NEW YORK, Aug. 17, 2012 (GLOBE NEWSWIRE) -- Shareholders of American Oriental Bioengineering, Inc. ("AOBI" or the "Company") (OTC:AOBI) are reminded of the federal securities class action filed...
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In American Oriental Bioengineering Inc. To Contact The Firm Regarding The August 22, 2012 Lead Plaintiff...
NEW YORK, Aug. 10, 2012 (GLOBE NEWSWIRE) -- Shareholders of American Oriental Bioengineering, Inc. ("AOBI" or the "Company")(OTC:AOBI) are reminded of the federal securities class action filed...
The Law Offices of Todd M. Garber announces that a class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of a...
NEW YORK, July 27, 2012 (GLOBE NEWSWIRE) -- The Rosen Law Firm, P.A. reminds investors of the important August 22, 2012 lead plaintiff deadline in the class action the Rosen Law Firm filed on...
NEW YORK, July 27, 2012 (GLOBE NEWSWIRE) -- Shareholders of American Oriental Bioengineering, Inc. ("AOBI" or the "Company") (OTC:AOBI) are reminded of the federal securities class action filed...
Law Offices of Howard G. Smith announces that all purchasers of the securities of American Oriental Bioengineering, Inc. (“AOBI” or the “Company”) (OTC:AOBI) between November 9...
Cohen Milstein Sellers & Toll PLLC is conducting an investigation to determine whether American Oriental Bioengineering, Inc. (“AOBI” or the “Company”) and certain of its...
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of a...
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In American Oriental Bioengineering Inc. To Contact the Firm PR Newswire NEW YORK, July 13, 2012 NEW YORK, July...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0.0005 | 0.0005 | 0.0005 | 1 | 0.0005 | CS |
52 | 0 | 0 | 0.0005 | 0.0005 | 0.0005 | 0 | 0.0005 | CS |
156 | 0.0003 | 150 | 0.0002 | 0.0005 | 0.0002 | 46 | 0.00046661 | CS |
260 | -4.9995 | -99.99 | 5 | 6.75 | 0.0002 | 200 | 1.9622292 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales